Pancare Foundation supports medical research that aims to accelerate advancement in early detection, new treatments, enhanced patient care and clinical trials that help improve outcomes for Australians impacted by pancreatic, liver, stomach, biliary and oesophageal cancers.
We fund world-class research at some of Australia’s most respected and innovative institutions. Our research program is overseen by our Medical Advisory Committee and underpinned by six key focus areas that will help us achieved improved survival rates.
Pancare Foundation funded research
Implantable drug-eluting device: localised drug delivery for non-resectable pancreatic cancer (jointly funded through Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme, PdCCRS)
Institution: University of Wollongong
Chief Investigator: Dr Kara Vine-Perrow
Improving the treatment of pancreatic cancer by Novel Treatment Therapies including studying the role of Cannabinoids
Institution: The University of Melbourne
Chief Investigator: A/Prof Mehrdad Nikfarjam
Funding early detection
Pancreatic Cancer Familial Screening Program
- St Vincent’s Hospital (Sydney)
- Austin Hospital (Melbourne)
- Royal Brisbane Hospital (Brisbane)
- Charles Gardiner Hospital (Perth)
Chief Investigator: Dr Alina Stoita
PURPLE Translational Registry
Institution: Walter and Eliza Hall Institute – WEHI
Chief Investigator: Dr Belinda Lee
Upper Gastrointestinal Cancer Registry (UGICR)
Institution: Monash University
Chief Investigator: Professor John Zalcberg
Consultations and submissions
As the leading Australian organisation for pancreatic and upper GI cancer, Pancare regularly advocates for initiatives that will improve the care of and support for Australians living with pancreatic, liver, stomach, biliary and oesophageal cancers.
Our team reviews and provides statements to engage government and other organisations regarding healthcare services; optimal care pathways; clinical trials, research and registries; supportive care; TGA activities; and other initiatives that will improve the lives and outcomes of those with upper GI cancer, their carers and families.
Pancare recognises that fostering an engaged clinical research community is a major factor in developing research and clinical trials that will progress the therapies for upper GI cancer into the future.
If you are a clinician or scientist undertaking research on upper GI cancer or have a PhD or Masters and are looking for scholarships or awards for your upper GI cancer-related research, please contact us to find out more about what potential opportunities Pancare has for supporting your research.
Learn more about the research programs we support and how you can help make a difference.